Comparison of antral follicle count, antimullerian hormone and day 2 follicle stimulating hormone as predictor of ovarian response and clinical pregnancy rate in patient with an abnormal ovarian reserve test


  • Jayakrishnan Krishnakumar KJK Hospital, Trivandrum, Kerala, India
  • Akansha Agarwal KJK Hospital, Trivandrum, Kerala, India
  • Divya Nambiar KJK Hospital, Trivandrum, Kerala, India
  • Shankar Radhakrishnan VMKVMCH, Salem, Tamil Nadu, India



AFC, AMH, FSH, Controlled ovarian hyperstimulation, Gonadotropin releasing hormone antagonist


Background: Patients having abnormal ovarian reserve test are likely to have poor response to controlled ovarian stimulation (COS) in artificial reproduction technique, where large number of follicles is desirable. Although direct measurement of the primordial follicle pool is impossible, it has been shown that the number of antral follicles in the ovaries is proportionally related to the size of primordial follicle stock from which they were recruited. Therefore, the antral follicle count (AFC) is believed to represent the quantitative aspect of ovarian aging. The aim of the study was to To compare the  day two Antral follicle count, antimullerian hormone and  Follicle stimulating hormone levels as a predictor of ovarian response among the patients undergoing controlled ovarian stimulation using GnRH antagonist and its implications in clinical pregnancy rate.

Methods: A prospective study was conducted in KJK Hospital Trivandrum on 119 patients having abnormal ovarian reserve test undergoing controlled ovarian stimulation (COS) with GnRH antagonist protocol from January 2010- December 2015. Patients AFC, AMH and FSH levels were measured and their association in predicting the ovarian reserve in terms of oocyte maturation, fertilization and embryo cleavage and their pregnancy rate.

Results: AFC had the highest accuracy for predicting ovarian response in patient with abnormal ovarian reserve test and was statistically significant (number of oocyte aspirated p value <0.001) than AMH (p value 0.06) and FSH (p value 0.212) in predicting ovarian response. For prediction of poor ovarian response a model including AFC+AMH was found to be almost similar to that of (p value 0.001) using AFC alone. However AFC (p value 0.458), AMH (p value 0.267) and FSH (p value 0.486) did not predict pregnancy rate in patient with abnormal ovarian reserve test and it was statistically not significant.

Conclusions: This study indicates that AFC is the most useful marker in predicting the ovarian response. Doing AFC assessment alone would be more cost effective for predicting the ovarian response in patients undergoing controlled ovarian stimulation with GnRH antagonist.


Hughes EG, King C, Wood EC. A prospective study of prognostic factors in in vitro fertilization and embryo transfer. Fertil Steril. 1989;51:838-44.

Meldrum DR. Female reproductive aging-ovarian and uterine factors. Fertil Steril. 1993;59:1-5.

Pearlstone AC, Fournet N, Gambone JC, Pang SC, Buyalos RP. Ovulation induction in women age 40 and older: the importance of basal follicle stimulating hormone level and chronological age. Fertil Steril. 1992;58:674-9.

Toner JP. The significance of elevated FSH for reproductive function. Baillieres Clin Obstet Gynaecol. 1993;7:283-95.

Buckman A, Heineman MJ. Ovarian reserve testing and the use of prognostic models in patients with sub fertility. Hum Reprod Update. 2001;7:581-90.

Ranieri DM, Phophong P, Khadum I, Meo F, Davis C, Serhal P. Simultaneous evaluation of basal FSH and oestradiol response to GnRH analogue (F -G-test) allows effective drug regimen selection for IVF. Hum Reprod. 2001;16:673-5.

Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685-718.

van Disseldorp J, Eijkemans MJ, Klinkert ER, te Velde ER, Fauser BC, Broekmans FJ. Cumulative live birth rates following IVF in 41 to 43 year-old women presenting with favourable ovarian reserve characteristics. Reprod Biomed Online. 2007;14:455-63.

Hendriks DJ, Mol BW, Bancsi LF, te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril. 2005;83:291-301.

La Marca A, Malmusi S, Giulini S, Tamaro LF, Orvieto R, Levratti P, et al. Anti mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Hum Reprod. 2004;19:2738-41.

Cook CL, Siow Y, Taylor S, Fallat ME. Serum mullerianinhibiting substance levels during normal menstrual cycles. Fertil Steril. 2000;73:859-61.

La Marca A, Stabile G, Artenisio AC, Volpe A. Serum antimullerian hormone throughout the human menstrual cycle. Hum Reprod. 2006;21:3103-7.

van Rooij IA, de Jong E, Broekmans FJ, Looman CW, Habbema JD, te Velde ER. High follicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment. Fertil Steril. 2004;81:1478-85.

Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, et al. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010;94:1044-51.

Andersen AN, Witjes H, Gordon K, Mannaerts B. Xpect investigators. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Hum Reprod. 2011;26:3413-23.

Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in goodprognosis patients. Fertil Steril. 2013;99:1644-53.

Hamdine O, Eijkemans MJ, Lentjes EW, Torrance HL, Macklon NS, et al. Ovarian response prediction in GnRH antagonist treatment for IVF using antiMüllerian hormone. Hum Reprod. 2015;30:170-8.

Polyzos NP, Nelson SM, Stoop D, Nwoye M, Humaidan P, et al. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilizationintracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study. Fertil Steril. 2013;100:438-44.

DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-45.

Vuong TNL, Vo MT, Ho MT. Predictive Value of AMH, FSH and AFC for Determining Ovarian Response in Vietnamese Women Undergoing Assisted Reproductive Technologies: A Prospective Study. JFIV Reprod Med Genet. 2015;3:151.

Mutlu MF, Erdem M, Erdem A, Yildiz S, Mutlu I. Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles. J Assist Reprod Genet. 2013;30: 657-65.






Original Research Articles